Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;18(1):1-3.
doi: 10.1007/s11302-021-09831-5. Epub 2022 Jan 3.

Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis

Michelle C Fletcher  1
Affiliations

Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis

Michelle C Fletcher. Purinergic Signal. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

References

    1. Davenport AJ, Neagoe I, Bräuer N, Koch M, Rotergi A, Nagel J, Laux-Biehlmann A, Machet F, Coelho AM, Boyce S, Carty N, Gemkow MJ, Hess SD, Zollner TM, Fischer OM. Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers. Sci Rep. 2021;11:19877. doi: 10.1038/s41598-021-99177-0. - DOI - PMC - PubMed
    1. Cockayne D, Hamilton S, Zhu QM, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 2000;407:1011–1015. doi: 10.1038/35039519. - DOI - PubMed
    1. Cockayne DA, Dunn PM, Zhong Y, et al. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol. 2005;567:621–639. doi: 10.1113/jphysiol.2005.088435. - DOI - PMC - PubMed
    1. Novakovic SD, Kassotakis LC, Oglesby IB, Smith JAM, Eglen RM, Ford APDW, Hunter JC. Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain. 1999;22(10):273–282. doi: 10.1016/S0304-3959(98)00225-5. - DOI - PubMed
    1. Pijacka W, Moraes D, Ratcliffe L, et al. Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nat Med. 2016;22:1151–1159. doi: 10.1038/nm.4173. - DOI - PMC - PubMed

Publication types

Substances

Associated data